This program is oriented to the development of tools for diagnosis, prognosis and advanced or targeted therapies in personalized medicine. In particular, the parties express their willingness to identify, as appropriate, as areas of future collaboration for the development of the Program, the following lines of action (LA):
- LA-1: BREM platform of electronic cryomicroscopy applied to personalized medicine.
- LA-2: [Implementation and analysis of databases in precision medicine].
- LA-3: Drug screening platform and analysis interactions fármaco-diana.LA-4: Development of biological models for screening and study of the activity of therapeutic molecules.
- LA-5: Development of nanodrugs, biodistribution, toxicity and therapeutic actions in pathology models.
- LA-6: Techniques and processes for advanced and targeted therapies, surgical training and medical robotics.
The program was initially launched with the Autonomous Communities of Catalonia, Castilla-La Mancha, Extremadura, the Basque Country and Galicia, through the signing of a framework agreement with the Ministry of Science, Innovation and Universities. Subsequently, following the Agreement of the Scientific, Technological and Innovation Policy Council of 22 June 2022, the Autonomous Communities of Galicia, Andalusia and Aragon have been incorporated.
